insights_auto
Why is ONCY up 2.87%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
$0.56
arrow_upward
+2.87%(+0.016) 1D
Oct 9, 3:23:03 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.55
High
$0.57
Low
$0.52
Mkt. cap
74.03M
Avg. vol.
1.05M
Volume
1.27M
52-wk high
$1.32
52-wk low
$0.52
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.55
High
$0.57
Low
$0.52
Mkt. cap
74.03M
Avg. vol.
1.05M
Volume
1.27M
52-wk high
$1.32
52-wk low
$0.52
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
TradingView
·
52 minutes ago
S&P 500 flatline masks historic churn across individual stocks - Nomura
Barron's
·
1 hour ago
S&P 500 Dividend Yield Hits Historic Lows: 5 Dividend ETFs to Consider
Coinpaper
·
38 minutes ago
Stock Market Today: Dow, S&P 500 and Nasdaq Rise as Oil Falls, Telecom Stocks Crash
Proactive financial news
·
2 hours ago
Frank Talk: Gold miners beat every S&P 500 sector in Q3 despite September selloff
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com